Cytomegalovirus?HHV-5?Infection Therapeutic Drugs Market, Global Outlook and Forecast 2022-2028

March 2022 | 113 pages | ID: CC19481B6F24EN
Market Monitor Global

Abstracts

A drug used to treat giant cell infections.

This report contains market size and forecasts of Cytomegalovirus?HHV-5?Infection Therapeutic Drugs in Global, including the following market information:

Global Cytomegalovirus?HHV-5?Infection Therapeutic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cytomegalovirus?HHV-5?Infection Therapeutic Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cytomegalovirus?HHV-5?Infection Therapeutic Drugs include 3-V Biosciences, Inc., AIMM Therapeutics, AlphaVax, Altor BioScience, Applied Immune, Astellas, BioApex, Bionor Pharma and Biotest, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cytomegalovirus?HHV-5?Infection Therapeutic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cytomegalovirus?HHV-5?Infection Therapeutic Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cytomegalovirus?HHV-5?Infection Therapeutic Drugs Market Segment Percentages, by Type, 2021 (%)

• Oral Medication
• Injection

Global Cytomegalovirus?HHV-5?Infection Therapeutic Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cytomegalovirus?HHV-5?Infection Therapeutic Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Other

Global Cytomegalovirus?HHV-5?Infection Therapeutic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cytomegalovirus?HHV-5?Infection Therapeutic Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cytomegalovirus?HHV-5?Infection Therapeutic Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cytomegalovirus?HHV-5?Infection Therapeutic Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• 3-V Biosciences, Inc.
• AIMM Therapeutics
• AlphaVax
• Altor BioScience
• Applied Immune
• Astellas
• BioApex
• Bionor Pharma
• Biotest
• Pfizer
• Cell Medica
• Chimerix
• GSK
• Hookipa Biotech
• Humabs BioMed
• Inagen
• Kadmon Corporation
• Lead Discovery Center
• Merck
• Novartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CYTOMEGALOVIRUS(HHV-5)INFECTION THERAPEUTIC DRUGS OVERALL MARKET SIZE

2.1 Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size: 2021 VS 2028
2.2 Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Players in Global Market
3.2 Top Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Companies Ranked by Revenue
3.3 Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size Markets, 2021 & 2028
  4.1.2 Oral Medication
  4.1.3 Injection
4.2 By Type - Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue & Forecasts
  4.2.1 By Type - Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Other
5.2 By Application - Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue & Forecasts
  5.2.1 By Application - Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2021 & 2028
6.2 By Region - Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue & Forecasts
  6.2.1 By Region - Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, 2017-2028
  6.3.2 US Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028
  6.3.3 Canada Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028
  6.3.4 Mexico Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, 2017-2028
  6.4.2 Germany Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028
  6.4.3 France Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028
  6.4.4 U.K. Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028
  6.4.5 Italy Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028
  6.4.6 Russia Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028
  6.4.8 Benelux Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, 2017-2028
  6.5.2 China Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028
  6.5.3 Japan Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028
  6.5.4 South Korea Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028
  6.5.6 India Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, 2017-2028
  6.6.2 Brazil Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028
  6.6.3 Argentina Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, 2017-2028
  6.7.2 Turkey Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028
  6.7.3 Israel Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028
  6.7.5 UAE Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 3-V Biosciences, Inc.
  7.1.1 3-V Biosciences, Inc. Corporate Summary
  7.1.2 3-V Biosciences, Inc. Business Overview
  7.1.3 3-V Biosciences, Inc. Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Major Product Offerings
  7.1.4 3-V Biosciences, Inc. Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global Market (2017-2022)
  7.1.5 3-V Biosciences, Inc. Key News
7.2 AIMM Therapeutics
  7.2.1 AIMM Therapeutics Corporate Summary
  7.2.2 AIMM Therapeutics Business Overview
  7.2.3 AIMM Therapeutics Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Major Product Offerings
  7.2.4 AIMM Therapeutics Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global Market (2017-2022)
  7.2.5 AIMM Therapeutics Key News
7.3 AlphaVax
  7.3.1 AlphaVax Corporate Summary
  7.3.2 AlphaVax Business Overview
  7.3.3 AlphaVax Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Major Product Offerings
  7.3.4 AlphaVax Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global Market (2017-2022)
  7.3.5 AlphaVax Key News
7.4 Altor BioScience
  7.4.1 Altor BioScience Corporate Summary
  7.4.2 Altor BioScience Business Overview
  7.4.3 Altor BioScience Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Major Product Offerings
  7.4.4 Altor BioScience Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global Market (2017-2022)
  7.4.5 Altor BioScience Key News
7.5 Applied Immune
  7.5.1 Applied Immune Corporate Summary
  7.5.2 Applied Immune Business Overview
  7.5.3 Applied Immune Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Major Product Offerings
  7.5.4 Applied Immune Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global Market (2017-2022)
  7.5.5 Applied Immune Key News
7.6 Astellas
  7.6.1 Astellas Corporate Summary
  7.6.2 Astellas Business Overview
  7.6.3 Astellas Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Major Product Offerings
  7.6.4 Astellas Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global Market (2017-2022)
  7.6.5 Astellas Key News
7.7 BioApex
  7.7.1 BioApex Corporate Summary
  7.7.2 BioApex Business Overview
  7.7.3 BioApex Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Major Product Offerings
  7.7.4 BioApex Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global Market (2017-2022)
  7.7.5 BioApex Key News
7.8 Bionor Pharma
  7.8.1 Bionor Pharma Corporate Summary
  7.8.2 Bionor Pharma Business Overview
  7.8.3 Bionor Pharma Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Major Product Offerings
  7.8.4 Bionor Pharma Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global Market (2017-2022)
  7.8.5 Bionor Pharma Key News
7.9 Biotest
  7.9.1 Biotest Corporate Summary
  7.9.2 Biotest Business Overview
  7.9.3 Biotest Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Major Product Offerings
  7.9.4 Biotest Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global Market (2017-2022)
  7.9.5 Biotest Key News
7.10 Pfizer
  7.10.1 Pfizer Corporate Summary
  7.10.2 Pfizer Business Overview
  7.10.3 Pfizer Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Major Product Offerings
  7.10.4 Pfizer Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global Market (2017-2022)
  7.10.5 Pfizer Key News
7.11 Cell Medica
  7.11.1 Cell Medica Corporate Summary
  7.11.2 Cell Medica Business Overview
  7.11.3 Cell Medica Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Major Product Offerings
  7.11.4 Cell Medica Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global Market (2017-2022)
  7.11.5 Cell Medica Key News
7.12 Chimerix
  7.12.1 Chimerix Corporate Summary
  7.12.2 Chimerix Business Overview
  7.12.3 Chimerix Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Major Product Offerings
  7.12.4 Chimerix Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global Market (2017-2022)
  7.12.5 Chimerix Key News
7.13 GSK
  7.13.1 GSK Corporate Summary
  7.13.2 GSK Business Overview
  7.13.3 GSK Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Major Product Offerings
  7.13.4 GSK Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global Market (2017-2022)
  7.13.5 GSK Key News
7.14 Hookipa Biotech
  7.14.1 Hookipa Biotech Corporate Summary
  7.14.2 Hookipa Biotech Business Overview
  7.14.3 Hookipa Biotech Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Major Product Offerings
  7.14.4 Hookipa Biotech Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global Market (2017-2022)
  7.14.5 Hookipa Biotech Key News
7.15 Humabs BioMed
  7.15.1 Humabs BioMed Corporate Summary
  7.15.2 Humabs BioMed Business Overview
  7.15.3 Humabs BioMed Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Major Product Offerings
  7.15.4 Humabs BioMed Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global Market (2017-2022)
  7.15.5 Humabs BioMed Key News
7.16 Inagen
  7.16.1 Inagen Corporate Summary
  7.16.2 Inagen Business Overview
  7.16.3 Inagen Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Major Product Offerings
  7.16.4 Inagen Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global Market (2017-2022)
  7.16.5 Inagen Key News
7.17 Kadmon Corporation
  7.17.1 Kadmon Corporation Corporate Summary
  7.17.2 Kadmon Corporation Business Overview
  7.17.3 Kadmon Corporation Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Major Product Offerings
  7.17.4 Kadmon Corporation Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global Market (2017-2022)
  7.17.5 Kadmon Corporation Key News
7.18 Lead Discovery Center
  7.18.1 Lead Discovery Center Corporate Summary
  7.18.2 Lead Discovery Center Business Overview
  7.18.3 Lead Discovery Center Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Major Product Offerings
  7.18.4 Lead Discovery Center Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global Market (2017-2022)
  7.18.5 Lead Discovery Center Key News
7.19 Merck
  7.19.1 Merck Corporate Summary
  7.19.2 Merck Business Overview
  7.19.3 Merck Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Major Product Offerings
  7.19.4 Merck Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global Market (2017-2022)
  7.19.5 Merck Key News
7.20 Novartis
  7.20.1 Novartis Corporate Summary
  7.20.2 Novartis Business Overview
  7.20.3 Novartis Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Major Product Offerings
  7.20.4 Novartis Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global Market (2017-2022)
  7.20.5 Novartis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Opportunities & Trends in Global Market
Table 2. Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Drivers in Global Market
Table 3. Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Restraints in Global Market
Table 4. Key Players of Cytomegalovirus(HHV-5)Infection Therapeutic Drugs in Global Market
Table 5. Top Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Type
Table 9. List of Global Tier 1 Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2023-2028
Table 30. 3-V Biosciences, Inc. Corporate Summary
Table 31. 3-V Biosciences, Inc. Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Offerings
Table 32. 3-V Biosciences, Inc. Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 33. AIMM Therapeutics Corporate Summary
Table 34. AIMM Therapeutics Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Offerings
Table 35. AIMM Therapeutics Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 36. AlphaVax Corporate Summary
Table 37. AlphaVax Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Offerings
Table 38. AlphaVax Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Altor BioScience Corporate Summary
Table 40. Altor BioScience Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Offerings
Table 41. Altor BioScience Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Applied Immune Corporate Summary
Table 43. Applied Immune Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Offerings
Table 44. Applied Immune Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Astellas Corporate Summary
Table 46. Astellas Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Offerings
Table 47. Astellas Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 48. BioApex Corporate Summary
Table 49. BioApex Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Offerings
Table 50. BioApex Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Bionor Pharma Corporate Summary
Table 52. Bionor Pharma Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Offerings
Table 53. Bionor Pharma Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Biotest Corporate Summary
Table 55. Biotest Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Offerings
Table 56. Biotest Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Pfizer Corporate Summary
Table 58. Pfizer Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Offerings
Table 59. Pfizer Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Cell Medica Corporate Summary
Table 61. Cell Medica Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Offerings
Table 62. Cell Medica Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Chimerix Corporate Summary
Table 64. Chimerix Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Offerings
Table 65. Chimerix Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 66. GSK Corporate Summary
Table 67. GSK Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Offerings
Table 68. GSK Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 69. Hookipa Biotech Corporate Summary
Table 70. Hookipa Biotech Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Offerings
Table 71. Hookipa Biotech Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 72. Humabs BioMed Corporate Summary
Table 73. Humabs BioMed Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Offerings
Table 74. Humabs BioMed Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 75. Inagen Corporate Summary
Table 76. Inagen Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Offerings
Table 77. Inagen Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 78. Kadmon Corporation Corporate Summary
Table 79. Kadmon Corporation Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Offerings
Table 80. Kadmon Corporation Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 81. Lead Discovery Center Corporate Summary
Table 82. Lead Discovery Center Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Offerings
Table 83. Lead Discovery Center Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 84. Merck Corporate Summary
Table 85. Merck Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Offerings
Table 86. Merck Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), (2017-2022)
Table 87. Novartis Corporate Summary
Table 88. Novartis Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Product Offerings
Table 89. Novartis Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Segment by Type in 2021
Figure 2. Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Segment by Application in 2021
Figure 3. Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue in 2021
Figure 8. By Type - Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 12. US Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 24. China Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. 3-V Biosciences, Inc. Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AIMM Therapeutics Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AlphaVax Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Altor BioScience Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Applied Immune Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Astellas Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. BioApex Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bionor Pharma Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Biotest Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Pfizer Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Cell Medica Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Chimerix Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. GSK Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Hookipa Biotech Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Humabs BioMed Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Inagen Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Kadmon Corporation Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Lead Discovery Center Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Merck Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Novartis Cytomegalovirus(HHV-5)Infection Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)